Abstract:Mitochondrial creatine kinase (mtCK) regulates the fast export of phosphocreatine to support cytoplasmic phosphorylation of ADP to ATP which is more rapid than direct ATP export. Such creatine-dependent phosphate shuttling is attenuated in several muscles, including the heart, of the D2.mdx mouse model of Duchenne muscular dystrophy at only 4 weeks of age. Here, we determined whether such attenuations occur in later stages in D2.mdx (12 months of age) in relation to mtCK thiol redox state, and whether this pathway could be preserved through administration of the mitochondrial-targeting, ROS-lowering tetrapeptide, SBT-20, in the D2.mdx mouse. In permeabilized muscle fibres prepared from cardiac left ventricles, we found that aged male D2.mdx mice have reduced creatine-dependent pyruvate oxidation and elevated complex I-supported H2O2 emission (mH2O2). Surprisingly, creatine-independent ADP-stimulated respiration was increased and mH2O2 was lowered suggesting that impairments in the faster mtCK-mediated phosphocreatine export system resulted in compensation of the alternative slower pathway of ATP export. The apparent impairments in mtCK-dependent bioenergetics occurred independent of mtCK protein content but were related to greater thiol oxidation of mtCK and a more oxidized cellular environment (lower GSH:GSSG). We then found that 12 weeks of daily treatment with SBT-20 (from day 4 to ~12 weeks of age) increased respiration and lowered mH2O2 only in the presence of creatine in D2.mdx mice without affecting calcium-induced mitochondrial permeability transition pore activity. In summary, creatine-dependent mitochondrial bioenergetics are attenuated in older D2.mdx mice in relation to mtCK thiol oxidation, which can be preserved with a ROS-lowering mitochondrial-targeting peptide. These results demonstrate a specific relationships between redox stress and metabolic reprogramming during dystrophin deficiency that can be targeted with small peptide therapeutics.

What problem does this paper attempt to address?

This paper attempts to address the issue of how the mitochondrial phosphate transport pathway deteriorates or adapts in the late stages of Duchenne muscular dystrophy (DMD) and whether these changes are related to the thiol oxidation state of mitochondrial creatine kinase (mtCK). Specifically, the researchers focused on two main aspects: 1. **Changes in the phosphate transport pathway**: - The researchers conducted a series of experiments to evaluate the changes in the creatine-dependent phosphate transport pathway (the faster pathway) and the creatine-independent phosphate transport pathway (the slower pathway) in 12-month-old D2.mdx mice (a mouse model of DMD). - They found that the creatine-dependent phosphate transport pathway was significantly impaired in D2.mdx mice, while the slower creatine-independent pathway showed compensatory enhancement. 2. **Thiol oxidation state of mtCK**: - The researchers further explored whether the thiol oxidation state of mtCK was related to the changes in the phosphate transport pathway. - They found that the thiol oxidation level of mtCK increased in the left ventricle of the heart in D2.mdx mice, which could be one of the reasons for the impairment of the creatine-dependent phosphate transport pathway. Additionally, the researchers conducted a proof-of-concept study to evaluate whether long-term administration of a mitochondria-targeted antioxidant peptide, SBT-20, to D2.mdx mice could improve creatine-dependent bioenergetic function. The results showed that SBT-20 was indeed able to partially restore the function of the creatine-dependent phosphate transport pathway. Overall, this paper aims to reveal the specific changes and mechanisms of the mitochondrial phosphate transport pathway in the late stages of DMD and to explore potential therapeutic strategies.

Disrupted cardiac bioenergetics linked to oxidized mitochondrial creatine kinase are rescued by the mitochondrial-targeting peptide SBT-20 in the D2.mdx model of Duchenne muscular dystrophy